Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

6.15
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
1.53
Today|||52-Week Range
8.84
+201.47%
Year-to-Date

Today’s Trading

Previous close6.15
Today’s open6.14
Day’s range5.89 - 6.15
Volume3,176,400
Average volume (3 months)3,643,133
Market cap$951.9M
Dividend yield--
Data as of 4:00pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)-154.93%
Earnings growth (this year)+42.51%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-49.72%
P/E ratioNM
Price/Sales4.13
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...-1.10-11.64%
NTLAIntellia Therapeutic...+0.18+0.91%
BOLDAudentes Therapeutic...+0.18+0.66%
AMAGAMAG Pharmaceuticals...-0.15-1.06%
Data as of 4:00pm ET, 11/17/2017

Financials

Next reporting dateFebruary 16, 2018
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$43.0M
Annual profit (last year)-$157.8M
Net profit margin-366.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts